Carmen B. Lozzio

1.8k total citations
55 papers, 1.2k citations indexed

About

Carmen B. Lozzio is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Carmen B. Lozzio has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Genetics. Recurrent topics in Carmen B. Lozzio's work include Monoclonal and Polyclonal Antibodies Research (7 papers), DNA and Nucleic Acid Chemistry (5 papers) and T-cell and B-cell Immunology (5 papers). Carmen B. Lozzio is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), DNA and Nucleic Acid Chemistry (5 papers) and T-cell and B-cell Immunology (5 papers). Carmen B. Lozzio collaborates with scholars based in United States, Argentina and France. Carmen B. Lozzio's co-authors include Bismarck B. Lozzio, Elena G. Bamberger, B B Lozzio, Stephen V. Lair, Carl J. Wust, John M. Opitz, Bryan D. Hall, Merlin G. Butler, James F. Reynolds and Amoz I. Chernoff and has published in prestigious journals such as Science, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Carmen B. Lozzio

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen B. Lozzio United States 17 492 402 218 209 174 55 1.2k
Eric G. Bremer United States 16 814 1.7× 394 1.0× 172 0.8× 115 0.6× 85 0.5× 19 1.5k
M B Prystowsky United States 15 681 1.4× 960 2.4× 334 1.5× 201 1.0× 125 0.7× 28 1.7k
F. Paraskevas Canada 21 498 1.0× 649 1.6× 317 1.5× 200 1.0× 56 0.3× 63 1.5k
Y Mory Israel 17 731 1.5× 309 0.8× 317 1.5× 270 1.3× 209 1.2× 26 1.5k
C Pénit France 25 383 0.8× 1.3k 3.2× 279 1.3× 127 0.6× 126 0.7× 47 1.8k
L C Andersson Finland 18 614 1.2× 273 0.7× 85 0.4× 107 0.5× 79 0.5× 23 1.1k
Marvin L. Tyan United States 16 290 0.6× 541 1.3× 74 0.3× 118 0.6× 194 1.1× 82 1.1k
Martin Johnson United States 15 731 1.5× 252 0.6× 137 0.6× 105 0.5× 416 2.4× 27 1.4k
Michael F. Seldin United States 21 1.0k 2.1× 889 2.2× 295 1.4× 116 0.6× 482 2.8× 39 2.3k
Claudie Lemercier France 20 1.1k 2.3× 334 0.8× 310 1.4× 151 0.7× 152 0.9× 33 1.6k

Countries citing papers authored by Carmen B. Lozzio

Since Specialization
Citations

This map shows the geographic impact of Carmen B. Lozzio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen B. Lozzio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen B. Lozzio more than expected).

Fields of papers citing papers by Carmen B. Lozzio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen B. Lozzio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen B. Lozzio. The network helps show where Carmen B. Lozzio may publish in the future.

Co-authorship network of co-authors of Carmen B. Lozzio

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen B. Lozzio. A scholar is included among the top collaborators of Carmen B. Lozzio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen B. Lozzio. Carmen B. Lozzio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, Erich J., et al.. (2000). PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro. Leukemia Research. 24(12). 1049–1057. 5 indexed citations
2.
Lozzio, Carmen B., et al.. (1999). Prenatal diagnosis of testicular feminization. Urology. 53(5). 1033–1033. 2 indexed citations
3.
Lubs, Herbert A., Louis J. Elsas, Avirachan T. Tharapel, et al.. (1993). Position statement on interphase in situ hybridization prenatal diagnosis. American Journal of Medical Genetics. 46(4). 478–478. 4 indexed citations
4.
Potter, Nicholas T., et al.. (1992). Use of a molecular genetic approach to diagnosing the fragile X genotype. The Journal of Pediatrics. 121(3). 385–390. 2 indexed citations
5.
Hodge, James W., et al.. (1991). Antibodies to Specific Cell Surface Antigens of a Human Leukemia Cell Line, K‐562, Transduce Negative Growth Signals. Annals of the New York Academy of Sciences. 628(1). 165–168. 3 indexed citations
6.
Walter, Harry, et al.. (1988). Detection of surface differences between closely related cell populations by partitioning. Cultured K-562 cell sublines. Cell Biophysics. 13(3). 173–187. 3 indexed citations
7.
Lozzio, Carmen B., et al.. (1987). Interferon-γInduced Expression of Class I HLA Antigens on K-562 Cells Grown in Serum-Free Medium. Journal of Interferon Research. 7(1). 87–93. 2 indexed citations
8.
Butler, Merlin G., et al.. (1987). Do some patients with seckel syndrome have hematological problems and/or chromosome breakage?. American Journal of Medical Genetics. 27(3). 645–649. 52 indexed citations
9.
Wust, Carl J., et al.. (1985). Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562.. PubMed. 59(1). 64–8. 6 indexed citations
10.
11.
Gérard, David, et al.. (1982). Arrest and extravasation of neoplastic cells. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 396(1). 73–89. 14 indexed citations
12.
Lozzio, Bismarck B. & Carmen B. Lozzio. (1979). Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leukemia Research. 3(6). 363–370. 205 indexed citations
13.
Lozzio, B B, et al.. (1976). Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells.. The Journal of Experimental Medicine. 143(1). 225–231. 35 indexed citations
14.
Lozzio, Carmen B., et al.. (1976). Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.. PubMed. 36(12). 4657–62. 36 indexed citations
15.
Lozzio, Carmen B. & Bismarck B. Lozzio. (1973). Cytotoxicity of a Factor Isolated From Human Spleen 2. JNCI Journal of the National Cancer Institute. 50(2). 535–538. 200 indexed citations
16.
Lozzio, Carmen B., et al.. (1970). Rapid Detection and Identification of Mucopolysaccharides in Urine. Clinical Pediatrics. 9(5). 272–276. 3 indexed citations
17.
Lozzio, Carmen B., et al.. (1969). Polyploïdie erythroblastique familiale bénigne avec anémie hémolytique et splénomégalie. Annals of Hematology. 18(6). 348–357. 4 indexed citations
18.
Lozzio, Carmen B.. (1968). Radiosensitivity of Ehrlich Ascites Tumour Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 14(2). 133–148. 3 indexed citations
19.
Lozzio, Carmen B., et al.. (1963). A CASE OF TRANSLOCATION 21-22/17-18. The Lancet. 281(7290). 1106–1106. 4 indexed citations
20.
Lozzio, Carmen B., et al.. (1963). ABSENCE OF GERMINAL EPITHELIUM WITH NORMAL KARYOTYPE. The Lancet. 282(7319). 1228–1229. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric G. Bremer Breakdown of academic impact, for papers by M B Prystowsky Breakdown of academic impact, for papers by F. Paraskevas Breakdown of academic impact, for papers by Y Mory Breakdown of academic impact, for papers by C Pénit Breakdown of academic impact, for papers by L C Andersson Breakdown of academic impact, for papers by Marvin L. Tyan Breakdown of academic impact, for papers by Martin Johnson Breakdown of academic impact, for papers by Michael F. Seldin Breakdown of academic impact, for papers by Claudie Lemercier
Rankless by CCL
2026